CWC Coffee Hour - Dr. Elena Koltun

Thursday, August 23, 2018 - 7:30am

Aug 28th (Tuesday) / 3 pm / K193
Please RSVP before Aug 27th (Monday), 11 am.

Elena Koltun is a Medicinal Chemist and a team leader with over 17 years of experience in the field of biotechnology, having worked previously for Exelixis and more recently, Numerate and Revolution Medicines. She has extensive experience in drug discovery and preclinical development across multiple therapeutic areas: oncology, metabolic syndrome, and inflammation, taking the programs from early Lead Generation and through IND enabling stage, including Lead Chemistry role for SHP2 program at Revolution Medicines.  Elena is a contributor to the delivery of five clinical candidates and the co-inventor of Cotellic® (Cobimetinib), MEK inhibitor developed by Exelixis and marketed since 2015 by Genentech.